BEST UNLIMITED TURBO LONG CERTIFICATE - AMGEN | Market Closed - Euronext Paris 17:30:01 28/05/2024 BST | ||
| 11.66 EUR | -5.20% |
|
| Current month | +24.49% | ||
| 1 month | +30.45% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
AMGEN INC.
Latest news about AMGEN INC.
More news
| Date | Price | Change |
|---|---|---|
| 28/05/24 | 11.66 | -5.20% |
| 27/05/24 | 12.3 | +0.21% |
| 24/05/24 | 12.28 | -2.49% |
| 23/05/24 | 12.59 | -2.21% |
| 22/05/24 | 12.88 | -0.29% |
Real-time Euronext Paris
Last update May 28, 2024 at 05:30 pm
More quotesStatic data
| Product type | Knock-Out without Stop Loss |
|---|---|
| Buy / Sell | CALL |
| Underlying | AMGEN INC. |
| Issuer | 
Société Générale
|
| DK72S | |
| ISIN | DE000SV6UUR9 |
| Date issued | 29/05/2023 |
| Strike | 176.2 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 5.26 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 14.72 € |
|---|---|
| Lowest since issue | 4.849 € |
Company Profile
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows:
- drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.;
- other (5.8%): primarily royalties.
The United States account for 70.3% of net sales.
Sector
-
Consensus: Amgen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
305.8
USD
Average target price
316.3
USD
Spread / Average Target
+3.41%
- Stock Market
- Certificates
- DK72S Certificat
